Hangzhou Tigermed Consulting Co., Ltd. (300347.SZ)
CNY 61.43
(-1.22%)
CNY 61.43
(-1.22%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.19 Billion | 1.35 Billion | 1.42 Billion | 998.67 Million | 527.55 Million | 522.24 Million |
| Net Income | 2.02 Billion | 2.27 Billion | 3.39 Billion | 2.02 Billion | 975.32 Million | 506.79 Million |
| Depreciation & Amortization | 339.02 Million | 264.74 Million | 188.92 Million | 144.74 Million | 43.26 Million | 58.19 Million |
| Deferred income taxes | -13.85 Million | -7.56 Million | 44.11 Million | 56.6 Million | -58.08 Million | 4.02 Million |
| Stock-based compensation | 20.23 Million | 46.64 Million | 83.24 Million | 31.42 Million | 36.74 Million | 2.61 Million |
| Change in working capital | -819.28 Million | -699.14 Million | -190.95 Million | 15.61 Million | -226.66 Million | 12.39 Million |
| Other non-cash items | 1.17 Billion | -526.77 Million | -2.09 Billion | -1.27 Billion | -243.02 Million | -55.14 Million |
| Investing Cash Flow | -1.89 Billion | -2.78 Billion | -2.78 Billion | -2.36 Billion | -638.15 Million | -366.53 Million |
| Investments in PPE | -313.75 Million | -448.6 Million | -368.61 Million | -156.49 Million | -102.91 Million | -91.71 Million |
| Acquisitions | -670.05 Million | -663.08 Million | -251.36 Million | -188.67 Million | -39.04 Million | -45.47 Million |
| Investment purchases | -2.14 Billion | -2.2 Billion | -3.18 Billion | -2.91 Billion | -1.01 Billion | -842.92 Million |
| Sales/Maturities of investments | 1.17 Billion | 430.28 Million | 1.06 Billion | 1.04 Billion | 515.05 Million | 602.11 Million |
| Other Investing Activities | 55.84 Million | 95.36 Million | -37.55 Million | -161.22 Million | 3.36 Million | 11.46 Million |
| Financing Cash Flow | 310.63 Million | 809.25 Million | -163.09 Million | 9.33 Billion | 1.43 Billion | 10.01 Million |
| Debt repayment | -683.77 Million | -1.83 Billion | -492.32 Million | -2.09 Billion | -1.07 Billion | -263.07 Million |
| Dividends payments | -475.72 Million | -432.46 Million | -261.72 Million | -208.22 Million | -174.63 Million | -126.64 Million |
| Common Stock Repurchased | -29.84 Million | -426.59 Million | -515.95 Million | -4 Million | -67.91 Million | -248.12 Million |
| Common Stock Issuance | 9.71 Million | 23.72 Million | 23.63 Million | 4 Million | 67.91 Million | - |
| Other Financing Activities | 271.6 Million | 3.53 Billion | 1.1 Billion | 11.7 Billion | 2.77 Billion | 399.73 Million |
| Accounts receivables | -719.46 Million | -869.24 Million | -808.73 Million | -142.27 Million | -282.89 Million | -180.7 Million |
| Accounts payables | -111.54 Million | 193.78 Million | 575.02 Million | 104.79 Million | 114.81 Million | 189.57 Million |
| Inventory | -4.36 Million | -16.1 Million | -1.37 Million | -3.51 Million | -504.69 Thousand | -504.86 Thousand |
| Other working capital | 16.09 Million | -7.56 Million | 44.11 Million | 56.6 Million | -58.08 Million | 12.9 Million |
| Cash at beginning of period | 7.8 Billion | 8.37 Billion | 9.95 Billion | 2.03 Billion | 698.18 Million | 525.22 Million |
| Cash at end of period | 7.4 Billion | 7.78 Billion | 8.37 Billion | 9.95 Billion | 2.03 Billion | 698.18 Million |
| Capital Expenditure | -313.75 Million | -448.6 Million | -368.61 Million | -156.49 Million | -102.91 Million | -91.71 Million |
| Effect of forex changes on cash | 8.79 Million | 26.93 Million | -59.56 Million | -47.48 Million | 15.19 Million | 7.23 Million |
| Net cash flow / Change in cash | -394.98 Million | -595.67 Million | -1.58 Billion | 7.92 Billion | 1.33 Billion | 172.96 Million |
| Free Cash Flow | 880.12 Million | 908.89 Million | 1.05 Billion | 842.17 Million | 424.64 Million | 430.52 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 320.58 Million | 257.77 Million | 235.07 Million | 145.24 Million | 2.02 Billion | 491.26 Million |
| Depreciation & Amortization | - | 90.18 Million | 90.18 Million | 88.46 Million | 339.02 Million | -146.69 Million |
| Deferred income taxes | - | 6.19 Million | - | 687.5 Million | -13.85 Million | -412.19 Million |
| Stock-based compensation | - | 47.98 Million | - | 20.23 Million | 20.23 Million | -55.39 Million |
| Change in working capital | - | -536.08 Million | - | -707.73 Million | -819.28 Million | 604.57 Million |
| Other non-cash items | 101.29 Million | -137.77 Million | -80.67 Million | 266.62 Million | 1.17 Billion | -183.95 Million |
| Investing Cash Flow | -1.1 Billion | -4.7 Billion | -129.9 Million | -525.15 Million | -1.89 Billion | -883.94 Million |
| Investments in PPE | -75.79 Million | -90.72 Million | -111.54 Million | -100.8 Million | -313.75 Million | -55.97 Million |
| Acquisitions | 174.66 Million | -195.68 Million | 241.78 Thousand | -573.11 Million | -670.05 Million | -344.16 Million |
| Investment purchases | -1.35 Billion | -4.56 Billion | -170.5 Million | -406.14 Million | -2.14 Billion | -779.83 Million |
| Sales/Maturities of investments | 352.55 Million | 134.74 Million | 152.15 Million | 518.13 Million | 1.17 Billion | 315.85 Million |
| Other Investing Activities | -20.37 Million | 14.1 Million | -264.77 Thousand | 36.76 Million | 55.84 Million | -19.83 Million |
| Financing Cash Flow | -478.21 Million | 399.35 Million | 2.42 Million | 78.23 Million | 310.63 Million | -146.2 Million |
| Debt repayment | -35.49 Million | -482.5 Million | -290.11 Million | -278.25 Million | -683.77 Million | -948.27 Million |
| Dividends payments | -544.69 Million | -33.89 Million | -30.26 Million | -475.72 Million | -475.72 Million | -503.55 Million |
| Common Stock Repurchased | 277.86 Million | -277.86 Million | - | -29.84 Million | -29.84 Million | -3.64 Million |
| Common Stock Issuance | - | - | - | 9.71 Million | 9.71 Million | 3.64 Million |
| Other Financing Activities | 30.98 Million | 258.15 Million | -287.68 Million | 1 Billion | 271.6 Million | 1.3 Billion |
| Accounts receivables | - | -585.33 Million | - | -719.46 Million | -719.46 Million | 600.24 Million |
| Accounts payables | - | - | - | - | -111.54 Million | 67.27 Million |
| Inventory | - | 1.26 Million | - | -4.36 Million | -4.36 Million | 4.33 Million |
| Other working capital | - | 47.98 Million | - | 16.09 Million | 16.09 Million | -67.27 Million |
| Cash at beginning of period | 3.16 Billion | 7.44 Billion | 7.4 Billion | 7.41 Billion | 7.8 Billion | 8.09 Billion |
| Cash at end of period | 1.96 Billion | 3.17 Billion | 7.44 Billion | 7.4 Billion | 7.4 Billion | 7.35 Billion |
| Capital Expenditure | -75.79 Million | -90.72 Million | -111.54 Million | -100.8 Million | -313.75 Million | -55.97 Million |
| Effect of forex changes on cash | -23.17 Million | 6.54 Million | -5.07 Million | -13.41 Million | 8.79 Million | -3.67 Million |
| Net cash flow / Change in cash | -1.2 Billion | -4.26 Billion | 32.54 Million | -8.13 Million | -394.98 Million | -736.22 Million |
| Free Cash Flow | 346.07 Million | -54.7 Million | 42.85 Million | 399.52 Million | 880.12 Million | 241.62 Million |
000738
ULTP
GULFNAV
QNCD
200725
SQI